Search Results for "2011 Waldenstrom Macroglobulinemia Update"
Original Source: Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.
Matching Channels
Top 50 Biopharma Products 2011
Ronald A. Rader, president of the Biotechnology Information Institute provided Contract Pharma a list of the Top 57 Biopharma Products by 2011 revenues (in millions). Mr. Rader subscribes to the sam...
Technical Background Tumor necrosis factor (TNF) is a substance made by your body's immune system. People with inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, psoriatic a...
On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...
Breast Implants - Augmentation
Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...
Matching News
Mutation ID'd in Waldenstrom's macroglobulinemia
(HealthDay)—MYD88 L265P is a common, recurring mutation in patients with Waldenström's macroglobulinemia, according to a study published in the Aug. 30 issue of the New England Journal of Medicine.
How to manage Waldenstrom’s macroglobulinemia
NEW YORK, Aug. 24, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (OTCBB:TGTX) today announced a poster presentation at the 7th International Workshop on Waldenström's Macroglobulinemia (WM), held i...
Mutation Linked to Rare Lymphoma (CME/CE)
(MedPage Today) -- A genetic mutation in patients with Waldenstrom's macroglobulinemia has been identified and may have implications for diagnosis and treatment of this lymphoplasmacytic lymphoma, res...
US FDA grants "breakthrough" status for Janssen and Pharmacyclics ibrutinib
US health care giant Johnson & Johnson (NYSE: JNJ) subsidiary Janssen Research & Development, says that the US Food and Drug Administration has granted Breakthrough Therapy Designations for the invest...
In Waldenstrm macroglobulinemia, fludarabine yields better survival than chlorambucil
NEW YORK (Reuters Health) - Fludarabine improves survival compared with chlorambucil in patients with Waldenstrm macroglobulinemia (WM) and related disorders, according to the multicenter WM1 stud...
Pharmacyclics planning follow-on
Pharmacyclics Inc. (NASDAQ:PCYC) said late Thursday it plans to sell 2.2 million shares in a follow-on underwritten by JPMorgan. If sold at Pharmacyclics' Thursday close of $94.20, the company would r...
[Pharmacyclics] nets $201mm through public offering
[Pharmacyclics Inc.] (therapies for cancer and immune-mediated diseases) netted $201mm through the public sale of 2.2mm common shares at $94.20. Some of the proceeds will go towards upcoming commercia...
Matching PubMed Articles
Bilateral ocular involvement as a presentation of Waldenström's macroglobulinemia.
We describe a 54 years old female with Waldenstrom's macroglobulinemia who presented with a bilateral ocular involvement. Ophthalmic involvement in Waldenstrom's macroglobulinemia is very rare. In add...
Spontaneous splenic rupture in Waldenstrom's macroglobulinemia: a case report.
ABSTRACT: INTRODUCTION: We report the case of a patient with Waldenstrom's macroglobulinemia complicated by spontaneous splenic rupture. CASE PRESENTATION: A 49-year-old Caucasian woman was referred t...
Peripheral capillary non-perfusion in asymptomatic Waldenstrom's macroglobulinemia.
ABSTRACT: BACKGROUND: To report the rare presentation of peripheral retinal ischemia in a patient with Waldenstrom's macroglobulinemia. Case Presentation A 39- year old man with a recent diagnosis of...
Many novel therapeutic agents are being tested in clinical trials for Waldenstrom macroglobulinemia (WM). However, given the paucity of large clinical trials in WM, the establishment of a standard tre...
How to manage Waldenstrom's macroglobulinemia.
Waldenstrom's macroglobulinemia (WM) is very distinct from other indolent lymphoma subtypes: by definition it is accompanied by a monoclonal IgM gammopathy, it presents always with bone marrow infiltr...
